BSE Live
Oct 15, 12:29Prev. Close
1685.80
Open Price
1666.05
Bid Price (Qty.)
1675.80 (6)
Offer Price (Qty.)
1680.20 (10)
NSE Live
Oct 15, 12:29Prev. Close
1685.80
Open Price
1682.90
Bid Price (Qty.)
1677.00 (34)
Offer Price (Qty.)
1679.00 (4)
Balance Sheet of Epigral (in Rs. Cr.) | Mar 20 | Mar 19 | |
12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | |||
SHAREHOLDER'S FUNDS | |||
Equity Share Capital | 41.55 | 41.19 | |
Total Share Capital | 41.55 | 252.11 | |
Reserves and Surplus | 331.00 | 240.66 | |
Total Reserves and Surplus | 331.00 | 240.66 | |
Total Shareholders Funds | 372.55 | 492.77 | |
NON-CURRENT LIABILITIES | |||
Long Term Borrowings | 418.29 | 365.34 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | |
Other Long Term Liabilities | 5.33 | 7.81 | |
Long Term Provisions | 1.55 | 1.12 | |
Total Non-Current Liabilities | 425.17 | 374.27 | |
CURRENT LIABILITIES | |||
Short Term Borrowings | 19.72 | 2.37 | |
Trade Payables | 46.79 | 36.34 | |
Other Current Liabilities | 198.22 | 138.42 | |
Short Term Provisions | 0.09 | 0.05 | |
Total Current Liabilities | 264.82 | 177.17 | |
Total Capital And Liabilities | 1,273.46 | 1,044.21 | |
ASSETS | |||
NON-CURRENT ASSETS | |||
Tangible Assets | 440.17 | 294.72 | |
Intangible Assets | 0.00 | 0.00 | |
Capital Work-In-Progress | 691.16 | 468.25 | |
Other Assets | 0.00 | 0.00 | |
Fixed Assets | 1,131.33 | 762.96 | |
Non-Current Investments | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.95 | 0.28 | |
Long Term Loans And Advances | 0.00 | 0.00 | |
Other Non-Current Assets | 9.10 | 26.65 | |
Total Non-Current Assets | 1,141.38 | 789.89 | |
CURRENT ASSETS | |||
Current Investments | 0.00 | 0.00 | |
Inventories | 48.40 | 40.65 | |
Trade Receivables | 76.45 | 77.36 | |
Cash And Cash Equivalents | 0.10 | 129.21 | |
Short Term Loans And Advances | 0.18 | 0.36 | |
OtherCurrentAssets | 6.96 | 6.73 | |
Total Current Assets | 132.08 | 254.32 | |
Total Assets | 1,273.46 | 1,044.21 | |
OTHER ADDITIONAL INFORMATION | |||
CONTINGENT LIABILITIES, COMMITMENTS | |||
Contingent Liabilities | 82.77 | 121.92 | |
CIF VALUE OF IMPORTS | |||
Raw Materials | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | |||
Expenditure In Foreign Currency | 122.54 | 112.09 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
Dividend Remittance In Foreign Currency | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | |||
FOB Value Of Goods | 31.39 | 35.67 | |
Other Earnings | -- | -- | |
BONUS DETAILS | |||
Bonus Equity Share Capital | -- | -- | |
NON-CURRENT INVESTMENTS | |||
Non-Current Investments Quoted Market Value | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | |
CURRENT INVESTMENTS | |||
Current Investments Quoted Market Value | -- | -- | |
Current Investments Unquoted Book Value | -- | -- |
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
06.05.2025
Epigral Standalone March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y
06.05.2025
Epigral Consolidated March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y